AP NEWS

Open-Angle Glaucoma Pipeline Insights, 2019 Research Report - ResearchAndMarkets.com

January 28, 2019

DUBLIN--(BUSINESS WIRE)--Jan 28, 2019--The “Open-Angle Glaucoma - Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.

“Open-Angle Glaucoma - Pipeline Insight, 2019 report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Open-Angle Glaucoma development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

The report assesses the active Open-Angle Glaucoma pipeline products by developmental stage, product type, molecule type, and administration route.

Key Topics Covered:

1. Report Introduction

2. Open-Angle Glaucoma Overview

3. Pipeline Therapeutics

An Overview of Pipeline Products for Open-Angle Glaucoma

4. Comparative Analysis

5. Products in Clinical Stage

Product Description Research and Development Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

Product Description Research and Development Product Development Activities

7. Therapeutic Assessment

Assessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type

8. Inactive Products

Product Description Research and Development Product Development Activities

Companies Mentioned

Aerie Pharmaceuticals Allergan Plc Amakem NV Asahi Kasei Pharma Corp. Bausch & Lomb Incorporated F. Hoffmann-La Roche Ltd. Inotek Pharmaceuticals Corporation Kowa Company

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/tk5fhs/openangle?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190128005369/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Optical Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH OPTICAL PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/28/2019 09:10 AM/DISC: 01/28/2019 09:11 AM

http://www.businesswire.com/news/home/20190128005369/en

AP RADIO
Update hourly